期刊文献+

5氮2脱氧胞苷与三苯氧胺协同抗雌激素受体Α阴性乳腺癌的体外实验研究 被引量:5

The synergistic inhibitory effect of 5-aza-2-deoxycytidine and Tamoxifen on estrogen receptor alpha negative breast cancer cell lines in vitro
原文传递
导出
摘要 目的观察5氮2脱氧胞苷(5-AZA-CDR)对雌激素受体Α(ERΑ)阴性人类乳腺癌细胞株MDA-MB-231和MDA-MB-435ERΑ基因诱导表达作用;5-AZA-CDR联合三苯氧胺(TAM)对ERΑ阴性乳腺癌细胞的体外抑制作用。方法应用甲基化特异性PCR(MSP)检测MDA-MB-231和MDA-MB-435细胞和20例ERΑ阴性乳腺癌组织ERΑ基因核心启动子区CPG岛甲基化情况;5-AZA-CDR处理MDA-MB-231和MDA-MB-435细胞,逆转录PCR(RT-PCR)检测ERΑMRNA表达;5-AZA-CDR、TAM分别或联合作用于MDA-MB-231和MDA-MB-435细胞,MTT比色法分析细胞生长抑制作用,流式细胞仪测定细胞周期分布和凋亡率。结果适当浓度的5-AZA-CDR能诱导MDA-MB-231和MDA-MB-435细胞表达ERΑMRNA,抑制细胞生长、阻滞细胞周期于G0/G1期,诱导细胞凋亡;TAM对MDA-MB-231和MDA-MB-435细胞生长、细胞周期无影响;而两药联合时能显著抑制细胞生长,诱导细胞凋亡,凋亡率分别为48.8%和53.1%。结论5-AZA-CDR能诱导ERΑ阴性乳腺癌表达ERΑMRNA,恢复ERΑ阴性乳腺癌细胞对TAM的敏感性,联合TAM能协同抑制ERΑ阴性乳腺癌细胞生长,诱导细胞凋亡,从而为ERΑ阴性乳腺癌开辟新的内分泌治疗途径提供实验依据。 Objective To observe if ER alpha gene can be induced by 5-aza-CdR in ER alpha negative human breast cancer cell lines (MDA-MB-231 and MDA-MB-435 ) and the synergistic inhibitory effects of 5-aza-CdR and Tamoxifen on these two cell lines in vitro. Methods The status of 5CpG island methylation of ER alpha gene in ER alpha negative (MDA-MB-231 and MDA-MB-435) human breast cancer cell lines and 20 cases of breast cancer tissue was studied by MSP, the expression of ER alpha mRNA was inspected by using RT-PCR after these two cell lines were treated with 5-aza-CdR. Cell proliferation was evaluated by MTT assay, distribution of cell cycle and rate of apoptosis were determined by flow cytometry after these two cell lines were treated with 5-aza-CdR or TAM alone, or in combination in vitro. Results The 5'CpG island is methylated in the core promotor of ER alpha gene in ER alpha negative (MDA-MB-231 and MDA-MB-435 ) human breast cancer cell lines and the methylating rate is 25.0% , 66. 7% , 83.3% , 100% in 20 cases of breast cancer tissue of stage Ⅰ,Ⅱ,Ⅲ, Ⅳ, respectively. The expression of ER alpha mRNA was induced in these two cell lines after treated with 5-aza-CdR, MTT array showed the proliferation activity of these two cell lines was obviously reduced in 5-aza-CdR group and the inhibitory effect on proliferation was enhanced when 5-aza-CdR combined with TAM compared with control group, the induction of apoptosis was 11.20% and 8. 71% respectively by 5-aza-CdR,while the rate of apoptosis is 48.8% and 53.1% when these two cells were treated with 5-aza-CdR combined with TAM. Conclusions 5-aza-CdR can re-express ER alpha by demethylating and sensitive ER alpha negative human breast cancer cell lines to TAM ,5-aza-CdR and TAM synergistically inhibite proliferation and induce apoptosis in ER alpha negative human breast cancer cell lines ,thus offer a new way for the treatment of ER alpha negative breast cancer.
出处 《中华外科杂志》 CAS CSCD 北大核心 2005年第23期1545-1549,共5页 Chinese Journal of Surgery
关键词 乳腺肿瘤 受体 雌激素 脱氧胞苷 甲基化 三苯氧胺 Breast neoplasms Receptors, estrogen Deoxycytidine Methylation Tamoxifen
  • 相关文献

共引文献3

同被引文献63

  • 1唐波,彭志红,姜军.肼苯哒嗪与三苯氧胺协同抗雌激素受体α阴性乳腺癌的研究[J].中华实验外科杂志,2005,22(5):538-540. 被引量:9
  • 2[1]Bauer KR,Brown M,Cress RD,et al.Descriptive analysis of estrogen receptor (ER)-negative,progesterone receptor(PR) -negative,and HER2 -negative invasive breast cancer,the so-called triple -negative phenotype:A population-based study from the California Cancer Registry.Cancer,2007,3
  • 3[2]Rakha EA,El-Sayed ME,Green AR.Prognostic markers in triple -negative breast cancer.Cancer,2007,109 (1):25
  • 4[3]Rodriguez-Pinilla SM,Sarrio D,Honrado E,et al.,Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas,Clin Cancer Re,2006,12:1533
  • 5[4]Cleator S,Heller W,Coombes RC.Triple -negative breast cancer:Therapeutic options.Lancet Oncol.2007,8 (3):235
  • 6[5]Livasy CA,Karaca G,Nanda R,et al.Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.Mod Pathol,2006,19:264
  • 7[6]Wang ZC,Lin M,Wei L J,et al.Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers,Cancer Res,2004,64:64
  • 8[7]Foulkes WD,Brunet JS,Stefansson IM,et al.The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation +) phenotype of BRCA1 -related breast cancer,Cancer Res,2004,64:830
  • 9[8]Turner N,Tutt A,Ashworth A.Hallmarks of ' BRCAness' in sporadic cancers,Nat Rev Cancer,2004,4:814
  • 10[9]Chappuis PO,Goffin J,Wong N,et al.A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer,J Med G enet,2002,39:608

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部